No Association of Multiple Sclerosis with <i>C9orf72</i> Hexanucleotide Repeat Size in an Austrian Cohort

No Association of Multiple Sclerosis with <i>C9orf72</i> Hexanucleotide Repeat Size in an Austrian Cohort

Multiple Sclerosis (MS) is a common immune-mediated disorder of the central nervous system that affects young adults and is characterized by demyelination and neurodegeneration. Recent studies have associated <i>C9orf72</i> intermediate repeat expansions with MS. The objective of this st...

Full description

Bibliographic Details
Main Authors:	Theresa König, Fritz Leutmezer, Thomas Berger, Alexander Zimprich, Christiane Schmied, Elisabeth Stögmann, Tobias Zrzavy
Format:	Article
Language:	English
Published:	MDPI AG 2023-07-01
Series:	International Journal of Molecular Sciences
Subjects:	genetic variants frontotemporal dementia (FTD) multiple sclerosis (MS) <i>C9orf72</i> repeat expansion intermediate repeat length disease heterogeneity
Online Access:	https://www.mdpi.com/1422-0067/24/14/11254

Similar Items

C9orf72 repeat length might influence clinical sub-phenotypes in dementia patients
by: Theresa König, et al.
Published: (2022-12-01)

<i>C9ORF72</i> Gene GGGGCC Hexanucleotide Expansion: A High Clinical Variability from Amyotrophic Lateral Sclerosis to Frontotemporal Dementia
by: Izaro Kortazar-Zubizarreta, et al.
Published: (2023-09-01)

<i>C9orf72</i> Hexanucleotide Repeat Expansion-Related Neuropathology Is Attenuated by Nasal Rifampicin in Mice
by: Yukari Hatanaka, et al.
Published: (2022-05-01)

Glial Cell Dysfunction in <i>C9orf72</i>-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
by: Mehdi Ghasemi, et al.
Published: (2021-01-01)

ALS’ Perfect Storm: <i>C9orf72</i>-Associated Toxic Dipeptide Repeats as Potential Multipotent Disruptors of Protein Homeostasis
by: Paulien H. Smeele, et al.
Published: (2024-01-01)

Enhanced insulin signalling ameliorates C9orf72 hexanucleotide repeat expansion toxicity in Drosophila
by: Magda L Atilano, et al.
Published: (2021-03-01)

Carriership of two copies of C9orf72 hexanucleotide repeat intermediate-length alleles is a risk factor for ALS in the Finnish population
by: Karri Kaivola, et al.
Published: (2020-11-01)

Role of C9orf72 hexanucleotide repeat expansions in ALS/FTD pathogenesis
by: Yanyan Geng, et al.
Published: (2024-01-01)

Altered network properties in C9ORF72 repeat expansion cortical neurons are due to synaptic dysfunction
by: Emma M. Perkins, et al.
Published: (2021-03-01)

Distribution of the C9orf72 hexanucleotide repeat expansion in healthy subjects: a multicenter study promoted by the Italian IRCCS network of neuroscience and neurorehabilitation
by: Emiliano Giardina, et al.
Published: (2024-01-01)

Disease Mechanisms and Therapeutic Approaches in <i>C9orf72</i> ALS-FTD
by: Keith Mayl, et al.
Published: (2021-05-01)

RNA Misprocessing in C9orf72-Linked Neurodegeneration
by: Holly V. Barker, et al.
Published: (2017-07-01)

BV-2 Microglial Cells Overexpressing C9orf72 Hexanucleotide Repeat Expansion Produce DPR Proteins and Show Normal Functionality but No RNA Foci
by: Hannah Rostalski, et al.
Published: (2020-10-01)

Young Onset Alzheimer’s Disease Associated with <i>C9ORF72</i> Hexanucleotide Expansion: Further Evidence for a Still Unsolved Association
by: Giulia Vinceti, et al.
Published: (2023-04-01)

<i>C9orf72</i>-G<sub>4</sub>C<sub>2</sub> Intermediate Repeats and Parkinson’s Disease; A Data-Driven Hypothesis
by: Hila Kobo, et al.
Published: (2021-08-01)

Knock in of a hexanucleotide repeat expansion in the C9orf72 gene induces ALS in rats
by: Wei Dong, et al.
Published: (2020-09-01)

A comparative bioinformatic analysis of C9orf72
by: Shalini Iyer, et al.
Published: (2018-02-01)

New Antibody-Free Mass Spectrometry-Based Quantification Reveals That C9ORF72 Long Protein Isoform Is Reduced in the Frontal Cortex of Hexanucleotide-Repeat Expansion Carriers
by: Arthur Viodé, et al.
Published: (2018-08-01)

Inducible expression of human C9ORF72 36× G4C2 hexanucleotide repeats is sufficient to cause RAN translation and rapid muscular atrophy in mice
by: Fréderike W. Riemslagh, et al.
Published: (2021-02-01)

C9ORF72 and the FTD-ALS spectrum: a systematic review of neuroimaging studies
by: Laura de Godoy Rousseff Prado, et al.

Dipeptide repeat proteins activate a heat shock response found in C9ORF72-ALS/FTLD patients
by: Daniel A. Mordes, et al.
Published: (2018-07-01)

Modeling C9orf72-Related Frontotemporal Dementia and Amyotrophic Lateral Sclerosis in Drosophila
by: Joanne L. Sharpe, et al.
Published: (2021-10-01)

The Enigmatic Role of C9ORF72 in Autophagy
by: Melissa Nassif, et al.
Published: (2017-08-01)

G-Quadruplexes Formation by the <i>C9orf72</i> Nucleotide Repeat Expansion d(GGGGCC)<sub>n</sub> and Conformation Regulation by Fangchinoline
by: Yun Zhang, et al.
Published: (2023-06-01)

Cell-to-Cell Transmission of Dipeptide Repeat Proteins Linked to C9orf72-ALS/FTD
by: Thomas Westergard, et al.
Published: (2016-10-01)

Reduced C9orf72 expression exacerbates polyGR toxicity in patient iPSC-derived motor neurons and a Type I protein arginine methyltransferase inhibitor reduces that toxicity
by: Therese L. Dane, et al.
Published: (2023-04-01)

Viral delivery of C9orf72 hexanucleotide repeat expansions in mice leads to repeat-length-dependent neuropathology and behavioural deficits
by: Saul Herranz-Martin, et al.
Published: (2017-07-01)

The Development of C9orf72-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Disorders
by: Qijie Yang, et al.
Published: (2020-09-01)

Unraveling the Role of RNA Mediated Toxicity of C9orf72 Repeats in C9-FTD/ALS
by: Vijay Kumar, et al.
Published: (2017-12-01)

Neuronal Transcriptome from C9orf72 Repeat Expanded Human Tissue is Associated with Loss of C9orf72 Function
by: Elaine Y. Liu, et al.
Published: (2020-08-01)

C9orf72 hexanucleotide repeat allele tagging SNPs: Associations with ALS risk and longevity
by: Karri Kaivola, et al.
Published: (2023-03-01)

Repeat‐associated non‐AUG translation in C9orf72‐ALS/FTD is driven by neuronal excitation and stress
by: Thomas Westergard, et al.
Published: (2019-02-01)

Soluble and insoluble dipeptide repeat protein measurements in C9orf72-frontotemporal dementia brains show regional differential solubility and correlation of poly-GR with clinical severity
by: Annelies Quaegebeur, et al.
Published: (2020-11-01)

Dipeptide Repeat Pathology in <i>C9orf72</i>-ALS Is Associated with Redox, Mitochondrial and NRF2 Pathway Imbalance
by: José Jiménez-Villegas, et al.
Published: (2022-09-01)

Emerging Perspectives on Dipeptide Repeat Proteins in C9ORF72 ALS/FTD
by: Alexander Schmitz, et al.
Published: (2021-02-01)

Biomarkers for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Associated With Hexanucleotide Expansion Mutations in C9orf72
by: Mary Kay Floeter, et al.
Published: (2018-12-01)

C9ORF72: What It Is, What It Does, and Why It Matters
by: Julie Smeyers, et al.
Published: (2021-05-01)

RNA-mediated toxicity in C9orf72 ALS and FTD
by: Zachary T. McEachin, et al.
Published: (2020-11-01)

C9ORF72 knockdown triggers FTD-like symptoms and cell pathology in mice
by: Maria-Belen Lopez-Herdoiza, et al.
Published: (2023-04-01)

Moderate intrinsic phenotypic alterations in C9orf72 ALS/FTD iPSC-microglia despite the presence of C9orf72 pathological features
by: Ileana Lorenzini, et al.
Published: (2023-06-01)